Wednesday, July 8, 2026

pharma · Breast Cancer · Breastcancer · BCTX

BriaCell Therapeutics

BriaCell Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Philadelphia, USA HQ
2004 Founded
24 Employees
Public company Type
BCTX · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2004
Employees
24
Programs
3
Drugs
0
Patents
1
Intelligence · Clinical Programs

BriaCell Therapeutics projects

2 ClinicalTrials.gov programs sponsored by BriaCell Therapeutics.

BriaCell Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BC1 cell line

    BriaCell Therapeutics

    Breast Cancer

    phase 2 mab active

    1 trial
  2. SV-BR-1-GM

    BriaCell Therapeutics

    Breastcancer

    phase 2 mab completed

    1 trial

Frequently asked questions

How many clinical projects does BriaCell Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.